Suppr超能文献

糖化白蛋白(GA)和 GA/HbA1c 比值评估用于糖尿病诊断和血糖控制的综合评价。

Evaluation of glycated albumin (GA) and GA/HbA1c ratio for diagnosis of diabetes and glycemic control: A comprehensive review.

机构信息

a Biomaterials Group, Faculty of Biomedical Engineering , Amirkabir University of Technology , Tehran , Iran.

b Marquette University School of Dentistry , Milwaukee , WI , USA.

出版信息

Crit Rev Clin Lab Sci. 2017 Jun;54(4):219-232. doi: 10.1080/10408363.2017.1299684. Epub 2017 Apr 10.

Abstract

Diabetes Mellitus (DM) is a group of metabolic diseases characterized by chronic high blood glucose concentrations (hyperglycemia). When it is left untreated or improperly managed, it can lead to acute complications including diabetic ketoacidosis and non-ketotic hyperosmolar coma. In addition, possible long-term complications include impotence, nerve damage, stroke, chronic kidney failure, cardiovascular disease, foot ulcers, and retinopathy. Historically, universal methods to measure glycemic control for the diagnosis of diabetes included fasting plasma glucose level (FPG), 2-h plasma glucose (2HP), and random plasma glucose. However, these measurements did not provide information about glycemic control over a long period of time. To address this problem, there has been a switch in the past decade to diagnosing diabetes and its severity through measurement of blood glycated proteins such as Hemoglobin A1c (HbA1c) and glycated albumin (GA). Diagnosis and evaluation of diabetes using glycated proteins has many advantages including high accuracy of glycemic control over a period of time. Currently, common laboratory methods used to measure glycated proteins are high-performance liquid chromatography (HPLC), immunoassay, and electrophoresis. HbA1c is one of the most important diagnostic factors for diabetes. However, some reports indicate that HbA1c is not a suitable marker to determine glycemic control in all diabetic patients. GA, which is not influenced by changes in the lifespan of erythrocytes, is thought to be a good alternative indicator of glycemic control in diabetic patients. Here, we review the literature that has investigated the suitability of HbA1c, GA and GA:HbA1c as indicators of long-term glycemic control and demonstrate the importance of selecting the appropriate glycated protein based on the patient's health status in order to provide useful and modern point-of-care monitoring and treatment.

摘要

糖尿病(DM)是一组以慢性高血糖为特征的代谢性疾病( hyperglycemia)。如果不进行治疗或管理不当,它可能导致急性并发症,包括糖尿病酮症酸中毒和非酮症高渗性昏迷。此外,可能的长期并发症包括阳痿、神经损伤、中风、慢性肾衰竭、心血管疾病、足部溃疡和视网膜病变。历史上,用于诊断糖尿病的血糖控制的通用方法包括空腹血浆葡萄糖水平(FPG)、2 小时血浆葡萄糖(2HP)和随机血浆葡萄糖。然而,这些测量值并不能提供长时间内血糖控制的信息。为了解决这个问题,在过去十年中,已经转向通过测量糖化蛋白(如血红蛋白 A1c(HbA1c)和糖化白蛋白(GA)来诊断糖尿病及其严重程度。使用糖化蛋白诊断和评估糖尿病有许多优点,包括在一段时间内对血糖控制的高度准确性。目前,用于测量糖化蛋白的常见实验室方法包括高效液相色谱法(HPLC)、免疫测定法和电泳法。HbA1c 是糖尿病最重要的诊断因素之一。然而,一些报告表明,HbA1c 不是所有糖尿病患者血糖控制的合适标志物。GA 不受红细胞寿命变化的影响,被认为是糖尿病患者血糖控制的良好替代指标。在这里,我们回顾了调查 HbA1c、GA 和 GA:HbA1c 作为长期血糖控制指标的适用性的文献,并证明了根据患者的健康状况选择合适的糖化蛋白的重要性,以提供有用的和现代的即时监测和治疗。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验